2018 Annual Meeting | C203 - Endovascular Treatment of Acute Stroke and Cerebrovascular Disease

Date Thursday 04/26/18

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Dileep R. Yavagal, MD, FAAN

Topic(s)

Learning Objectives Participants will be able to discuss the application of mechanical thrombectomy in AIS as the new standard of care. They will be able to review the latest endovascular techniques for aneurysms, AVMs, and dural AVFs; their indications for application in patients; and scientific evidence from the latest clinical trials. Participants will also be able to discuss how to tailor application of neuroendovascular therapies in individual case scenarios.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Tracks Neurohospitalist

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation, Panel Discussion

Event Timeline
03:30 PM - 03:35 PM	Luncheon	Introduction Dileep R. Yavagal, MD, FAAN
03:35 PM - 04:00 PM	Speaker	Mechanical Thrombectomy with IV Thrombolysis: How to Most Effectively Implement the New Standard of Care for Acute LVO Stroke? Dileep R. Yavagal, MD, FAAN
04:00 PM - 04:25 PM	Speaker	Current Imaging Selection in Stroke: Within 6 Hours, Wake-up and Beyond David S. Liebeskind, MD, FAAN
04:25 PM - 04:50 PM	Speaker	Advances in Endovascular Treatment of Brain Aneurysms, AVMs, and Dural AVFs Italo Linfante, MD
04:50 PM - 05:05 PM	Speaker	Current Indications for Carotid and Intracranial Stenting Dileep R. Yavagal, MD, FAAN
05:05 PM - 05:25 PM	Q&A	Questions and Answers
05:25 PM - 05:30 PM	Closing Remarks	Closing Remarks Dileep R. Yavagal, MD, FAAN

Faculty Disclosures
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Italo Linfante, MD	Dr. Linfante has received personal compensation for serving as an employee of medtronic. Dr. Linfante has received personal compensation for serving as an employee of stryker. Dr. Linfante has received personal compensation for serving as an employee of cerenovus. Dr. Linfante has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for medtronic. Dr. Linfante has received stock or an ownership interest from InNeuroCO. Dr. Linfante has received stock or an ownership interest from Stryker/Surpass.

��ɫ��

��ɫ��